[PDF][PDF] Therapeutics and COVID-19: living guideline, 31 March 2021
World Health Organization - 2021 - apps.who.int
World Health Organization
2021•apps.who.intwhat is this living guideline? Clinical question: What is the role of drugs in the treatment of
patients with COVID-19? Target audience: The target audiences are clinicians and health
care decision-makers. Current practice: The evidence base for therapeutics for COVID-19 is
increasing rapidly, and some treatments of proven benefit have emerged. Numerous
randomized trials of many drugs are underway to further inform practice. This version of the
WHO living guideline contains new information and a recommendation on ivermectin (1) …
patients with COVID-19? Target audience: The target audiences are clinicians and health
care decision-makers. Current practice: The evidence base for therapeutics for COVID-19 is
increasing rapidly, and some treatments of proven benefit have emerged. Numerous
randomized trials of many drugs are underway to further inform practice. This version of the
WHO living guideline contains new information and a recommendation on ivermectin (1) …
Summary
what is this living guideline?
Clinical question: What is the role of drugs in the treatment of patients with COVID-19?
Target audience: The target audiences are clinicians and health care decision-makers.
Current practice: The evidence base for therapeutics for COVID-19 is increasing rapidly, and some treatments of proven benefit have emerged. Numerous randomized trials of many drugs are underway to further inform practice. This version of the WHO living guideline contains new information and a recommendation on ivermectin (1). Increased international attention on ivermectin as a potential treatment for COVID-19 triggered this recommendation.
Recommendations: In this update, the panel makes a recommendation not to use ivermectin in patients with COVID-19 except in the context of a clinical trial. Previous recommendations include:
apps.who.int
以上显示的是最相近的搜索结果。 查看全部搜索结果